Comparing European and Japanese methods for examining colon cancer
Comparison Between the European and Japanese Pathological Investigation for Colon Cancer (SPACE)
This study is testing whether the way doctors in Japan check for colon cancer is as accurate as the method used in Europe for patients who have had surgery for colon cancer.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Enrollment | 430 (estimated) |
| Sex | All |
| Sponsor | Russian Society of Colorectal Surgeons Academic / other |
| Locations | 1 site (Moscow) |
| Trial ID | NCT06119867 on ClinicalTrials.gov |
What this trial studies
This study aims to compare the diagnostic accuracy of the European and Japanese pathological investigation methods for colon cancer. The European approach relies primarily on pathologists without surgical involvement, while the Japanese method includes surgeons in the evaluation process. The study will assess whether the Japanese method is less accurate than the European method, which has not been systematically evaluated in the literature. Patients diagnosed with colon cancer who have undergone colectomy will be included in the trial.
Who should consider this trial
Good fit: Ideal candidates are patients diagnosed with colon cancer who have undergone colectomy and have confirmed adenocarcinoma.
Not a fit: Patients with rectal cancer or those who have not undergone colectomy will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the accuracy of colon cancer diagnoses, leading to better treatment outcomes.
How similar studies have performed: There is limited literature on the Japanese pathological assessment method, making this a novel evaluation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with colon cancer who underwent colectomy; * Patients with pathological confirmed adenocarcinoma; * Patients agreed to participate in the study. Exclusion Criteria: * Patients suffered from rectal cancer; * Patients diagnosed with colon cancer but did not undergo colectomy; * Patients refused participation.
Where this trial is running
Moscow
- Clinic of coloproctology and minimally invasive surgery — Moscow, Russian Federation (Recruiting)
Study contacts
- Principal investigator: Vladimir Balaban — Sechenov University
- Study coordinator: Mingze He
- Email: hemingze97@gmail.com
- Phone: +79801881266
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.